Gianluca Sala
Chieti, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Galectin-3-binding protein is a risk factor for diabetes, metabolic syndrome, and inflammation. Cross-sectional and longitudinal results from the InCHIANTI study.
Journal: Mechanisms of ageing and development
Published: April 09, 2025
LGALS3BP antibody-drug conjugate enhances tumor-infiltrating lymphocytes and synergizes with immunotherapy to restrain neuroblastoma growth.
Journal: Journal of translational medicine
Published: January 13, 2025
A first-in-class non-cytotoxic nanocarrier based on a recombinant human ferritin boosts targeted therapy, chemotherapy and immunotherapy.
Journal: International journal of biological macromolecules
Published: January 09, 2025
Single-cell profiling reveals three endothelial-to-hematopoietic transitions with divergent isoform expression landscapes.
Journal: Nature cardiovascular research
Published: September 17, 2024
Human head and neck cancer cell lines response to cold atmospheric plasma activated media is affected by the chemistry of culture media.
Journal: Heliyon
Published: September 12, 2024
Proteomic meta-analysis unveils new frontiers for biomarkers research in pancreatic carcinoma.
Journal: Oncogenesis
Published: August 01, 2024
Fetal-restricted hematopoietic progenitors arise from hemogenic endothelium in vitelline and umbilical arteries.
Journal: Nature cardiovascular research
Published: July 01, 2024
Cold atmospheric plasma activated media selectively affects human head and neck cancer cell lines.
Journal: Oral diseases
Published: December 14, 2023
Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools.
Journal: Seminars in cancer biology
Published: December 01, 2023
Last Updated: 09/26/2026